Vouchercare for Cancer
The health care cost debate takes place on two stages using two languages, one scientific, the other economic. The net result is a failure to communicate. The health care cost…
How to Increase the Numbers of Women CEOs in Health IT
The appalling lack of women chief executives in today’s Health IT companies has been linked to a paucity of women in IT generally and the scarcity of female mentors and…
Health Care Buzz Today
Medicaid To Stop Paying for Preventable Events. The Centers for Medicare and Medicaid Services announced that it will no longer pay healthcare providers for treating Medicaid patients with illnesses, injuries…
Source of the E.Coli Breakout Could Be Bean Sprouts from Germany
The search continues and the latest potential source leads to their own farms in Germany, however it is stated as only a hot lead. The restaurant singled out where
Kinect Technology – A Grocery Cart that Can Follow The Wheelchair
This gets better all the time with the Kinect technology and this is still being developed as you can see in the video with bringing laptop with you to the…
The Future of Medicine: Do Pre-med Students Have a Clue?
At this writing, I am in Atlanta visiting our daughter at Emory University. This may be the only college campus in the nation where you can’t buy Pepsi. Coke is…
How to Be a Responsible Hospital Administrator
This is an issue really close to home for two reasons. First, this facility is truly in my neighborhood and second because I did some work for this agency in…
Advocating for Patients at ASCO, The “World Series” of Cancer
I am off to Chicago to mingle with 30,000+ people from around the world whose passion is curing cancer and helping people who are living with it. In years past…
Rationing the Doctor’s Time
In the early 1990s, prior to Medicaid and SCHIP expansions, physicians spent about the same number of minutes with both Medicaid and privately insured patients. By the year 2000, physicians…
How to Use Genomics to Treat Lung Cancer
Drug companies can use genomics to create targeted drugs like imatinib (Gleevec) and trastuzumab (Herceptin.) Physicians can then use the results of genomic studies to guide prescribing. As discussed in…
